Evaluate, Thanks for sharing. This sounds like the secret sauce of DCVax-Direct that is now and hereby protected by a patent.
LP is lining things up in a row. As a retail investor, I might not understand the full implications, but possibly a potential Pharma partner would see this as carving out an entire immunotherapy mechanism of action as a technology platform, available for licensing. If the potential for direct injection into a solid tumor without surgery proves out in trials, and is as big as it seems, then this secret sauce potentially becomes a cancer treatment holy grail.